Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

10:45 AM - 12:00 PM PT

Palliative Care 1: Palliative radiotherapy from SABR to EBRT: Improving QOL, prognostication, and toxicities
Speaker: Boersma, Melisa, MD, MS - University of Kansas Cancer Center, Kansas City, MO
10:45 AM - 12:00 PM PT

Palliative Care 1: Palliative radiotherapy from SABR to EBRT: Improving QOL, prognostication, and toxicities
Speaker: Alcorn, Sara, MD, PhD, MPH - 401 N Broaway, Baltimore, MD
10:45 AM - 12:00 PM PT

Patient Safety 1: Harnessing AI and Team Efforts to Enhance Patient Care through Workflow and Automation Improvements
Speaker: Sio, Terence, MD, MS - Mayo Clinic, Phoenix, AZ
10:45 AM - 12:00 PM PT

Patient Safety 1: Harnessing AI and Team Efforts to Enhance Patient Care through Workflow and Automation Improvements
Speaker: Quirk, Sarah, PhD - Dana-Farber/Brigham and Womens Cancer Center, Boston, MA
10:45 AM - 12:00 PM PT

Radiation and Cancer Biology 3: Normal Tissue Injury &  Biomarkers
Speaker: Mian, Omar, MD, PhD - Fred Hutchinson Research Center, Seattle, WA
10:45 AM - 12:00 PM PT

Radiation and Cancer Biology 3: Normal Tissue Injury &  Biomarkers
Speaker: Padilla, Oscar, MD - Mount Sinai Hospital, New York, NY
10:45 AM - 12:00 PM PT

Radiation and Cancer Physics 2: Imaging Biomakers for Response Monitoring
Speaker: Rosu, Mihaela, PhD - Virginia Commonwealth University, Richmond, VA
10:45 AM - 12:00 PM PT

Radiation and Cancer Physics 2: Imaging Biomakers for Response Monitoring
Speaker: Chen, Yingxuan, PhD - Thomas Jefferson University, Philadelphia, PA
10:55 AM - 11:05 AM PT

194 - Daily Online Adaptive Recontouring for Prostate Cancer Using 1.5 Tesla Magnetic Resonance Image Guidance (MRgRT) Improves Patient Reported Urinary Symptoms, A Prospective, International, Observational Cohort Study (NCT04075305)
Speaker: Hall, William, MD - Medical College of Wisconsin, Elm Grove, WI
10:55 AM - 11:05 AM PT

200 - TP53 Mutations and Outcomes after Radiotherapy in Mantle Cell Lymphoma
Speaker: Deshane, Alok, MD - MSKCC, New York, NY
10:55 AM - 11:05 AM PT

205 - Anlotinib Combined with Whole-Brain Radiotherapy for Brain Metastases in Patients Diagnosed with Small Cell Lung Cancer: A Single-Arm, Phase 2 Trial
Speaker: Deng, Lei - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
10:55 AM - 11:05 AM PT

212 - Predictors of Skeletal-Related Events and Quality of Life Dimensions among Patients with High-Risk, Asymptomatic Bone Metastases with or without Early Radiation Therapy: Secondary Analysis of a Multicenter, Randomized Phase II Clinical Trial
Speaker: Lapen, Kaitlyn, MD - Memorial Sloan Kettering Cancer Center, New York, NY